Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Toru Furusaka"'
Autor:
Kiyoshi Makiyama, Takeshi Oshima, Toru Furusaka, Ryoji Hirai, Hiroumi Matsuzaki, Hirotaka Suzuki
Publikováno v:
Journal of Voice. 30:761.e11-761.e17
Summary Objective Basic fibroblast growth factor promotes wound healing by accelerating healthy granulation and epithelialization. However, the duration of the effects of a single intracordal injection of basic fibroblast growth factor has not been e
Publikováno v:
Practica Oto-Rhino-Laryngologica. 83:577-587
A 42-year-old male with early malignant fibrous histiocytoma (MFH) of the maxillary sinus was treated with subtotal resection of the maxilla and has had no recurrence for 7 years and 9 months after surgery.Forty-four cases of MFH of the maxillary sin
Autor:
Koichi Ishiyama, Hidenobu Iida, Toru Furusaka, Fumitaka Sakai, Akinori Kida, Yoichiro Yamada, Sohei Endo
Publikováno v:
Auris, nasus, larynx. 22(3)
The subjects were 14 patients with squamous cell carcinoma or undifferentiated carcinoma of the nasal cavity treated at Nihon University Hospital between October 1984 and November 1991, who were followed for at least 3 years. The site of the tumor or
Publikováno v:
Nippon Jibiinkoka Gakkai Kaiho. 90:1223-1228
No effective tumor markers are available for squamous cell carcinoma of the head and neck region with the exception of immunosuppressive acidic protein (IAP). Recently, TA-4 was developed by Kato et al. as a marker of uterine cervical squamous cell c
Publikováno v:
Auris, nasus, larynx. 12
Measurements were carried out on the serum immunosuppressive acidic protein (IAP) level of patients with malignant head and neck tumors. The serum IAP value in patients with malignancies was significantly higher than that in healthy subjects and thos
Publikováno v:
Auris, nasus, larynx. 16
Twelve patients with advanced or relapsed head and neck adenocarcinoma received a combination chemotherapy regimen of either cyclophosphamide (C), tetrahydropyranyl-adriamycin (T), and cis -platinum (P) (CTP) or cyclophosphamide, adriamycin (A), and